Study title: Graf. P. (1996) Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperactivity. Rhinology, 34, 9-13.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Otorhinolaryngologic Diseases | |||||
Brands: Please see report, Please see report | |||||
MAH holders: Please see report, Please see report | |||||
Assessment: | |||||
Active substance: XYLOMETAZOLINE | |||||
ATC code: R01AA07 | |||||
Document link: | |||||
Document date: | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |